Exane Derivatives’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-15,440
| Closed | -$737K | – | 661 |
|
|
2018
Q4 | $737K | Buy |
+15,440
| New | +$737K | 0.13% | 131 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 670 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 654 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 608 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 575 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 561 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 609 |
|
|
2017
Q1 | – | Sell |
-10,240
| Closed | -$493K | – | 565 |
|
|
2016
Q4 | $493K | Buy |
+10,240
| New | +$493K | 0.1% | 139 |
|
|
2016
Q3 | – | Sell |
-12,785
| Closed | -$693K | – | 585 |
|
|
2016
Q2 | $693K | Buy |
12,785
+11,185
| +699% | +$606K | 0.11% | 107 |
|
|
2016
Q1 | $81.1K | Buy |
+1,600
| New | +$81.1K | 0.01% | 227 |
|
|
2015
Q4 | – | Sell |
-568
| Closed | -$27.3K | – | 499 |
|
|
2015
Q3 | $27.3K | Buy |
+568
| New | +$27.3K | ﹤0.01% | 262 |
|
|
2015
Q1 | – | Sell |
-8
| Closed | -$427 | – | 488 |
|
|
2014
Q4 | $427 | Buy |
+8
| New | +$427 | ﹤0.01% | 432 |
|